New report published by Global Info Research which offers insights on the global Bacterial Vaginosis Drug market.
Bacterial vaginosis is an imbalance of “good” and “bad” bacteria in the vagina, with there being more bad bacteria. Causes of an imbalance of bacteria can be caused by multiple sex partners and douching. Symptoms include odor, discharge, burning, and itching.
Click to view the full report TOC, figure and tables:
Global Bacterial Vaginosis Drug Market: Forecast by Type / Application / Region
Antibiotics are the mainstay of therapy for bacterial vaginosis. Medications include metronidazole (Flagyl), clindamycin (Cleocin) oral or vaginal suppositories, and metronidazole vaginal gel (MetroGel-Vaginal). Metronidazole and clindamycin are the preferred medications used to treat Gardnerella infections.
The major players in United States market include: Pfizer, Teva, Perrigo, Mylan, Lupin Pharmaceuticals, Prasco, West-Ward, Edenvridge.
On the basis of product, the Bacterial Vaginosis Drug market is primarily split into: Clindamycin, Metronidazole, Tinidazole, Other.
On the basis on the end users/applications covers: Hospital, Drug Store, Other.
In the last several years, United States market of Bacterial Vaginosis Drug developed stable, with an average growth rate of 2.7%. In 2016, United States revenue of Bacterial Vaginosis Drug is nearly 162 M USD.
The United States average price of Bacterial Vaginosis Drug is in the fluctuating trend, from 26.6/Unit in 2012 to 26.8 USD/Unit in 2016.
The classification of Bacterial Vaginosis Drug includes Clindamycin, Metronidazole, Tinidazole and others, and the proportion of Metronidazole in 2016 is about 40 and the revenue proportion of Clindamycin is about 27%.
Bacterial Vaginosis Drug is widely used in Hospital, Drug Store and other field. The most proportion of Bacterial Vaginosis Drug is in Drug Store, and the sales proportion in 2016 is about 53%.
South Atlantic is the largest consumption place, with a consumption market share nearly 24% in 2016. Following South Atlantic, Pacific is the second largest consumption place with the consumption market share of 23%.
Market competition is not intense. Pfizer, Teva, Perrigo, Mylan, Lupin Pharmaceuticals etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Ask for Discount on Research Report and Request Sample Copy of Report@
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
United States Bacterial Vaginosis Drug Market 2018 Forecast to 2023
Europe Bacterial Vaginosis Drug Market 2018 Forecast to 2023
North America Bacterial Vaginosis Drug Market 2018 Forecast to 2023
Asia-Pacific Bacterial Vaginosis Drug Market 2018 Forecast to 2023
China Bacterial Vaginosis Drug Market 2018 Forecast to 2023
EMEA Bacterial Vaginosis Drug Market 2018 Forecast to 2023
Global Bacterial Vaginosis Drug Market 2018 Forecast to 2023
Contact US :
Sales Director (Global Info Research)
Tel: +86-15521064060 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong